| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +26.1K | 100% | $1.92 | +$50K |
| Sells | 0 | ||||
| Net | +1 | +26.1K | 100% | +$50K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Faheem Hasnain | President & CEO, Director | $15.9M | Oct 1, 2025 | ||
| Waage Christian | EVP, Tech Ops and Admin | $2.07M | Oct 1, 2025 | ||
| Bryan Giraudo | Coo/Cfo | $2.01M | Oct 1, 2025 | ||
| Richard Aranda | Chief Medical Officer | $989K | Oct 1, 2025 | ||
| Robert Paul Smith JR | Chief Commercial Officer | $499K | Oct 1, 2025 | ||
| Caryn Peterson | EVP, Regulatory Affairs | $465K | Oct 1, 2025 | ||
| Sandra Milligan | Director | $111K | +$50K | +81.4% | Aug 19, 2025 |
| Laura Carter | Chief Scientific Officer | $60.1K | Mar 20, 2023 | ||
| John D. Quisel | Director | Jun 25, 2025 | |||
| Renee D. Gala | Director | Jun 8, 2023 | |||
| Kristina Burow | Director | Jun 8, 2023 | |||
| Joshua H. Bilenker | Director | Jun 9, 2022 | |||
| Russell J. Cox | Director | Jun 25, 2025 | |||
| Thomas O. Daniel | Director | Jun 25, 2025 | |||
| Skye Drynan | Director | Jun 25, 2025 | |||
| Steven D. Nathan | Director | Jun 25, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|